TABLE 2.
Monosubunit mutation and their locus and consequence.
| Mutant Subunit | Mutant Locus | Consequence |
|---|---|---|
| Kir 6.1 | Smooth muscle | Hypertension/hypotension |
| Lymphatic smooth muscle | Lymphatic contractile dysfunction lymphatic smooth muscle hyperpolarization | |
| Skeletal muscle | Reduced limb strength, skeletal muscle atrophy, autophagy, and myofibers connective tissue replacement | |
| S422L | Shortened repolarization in ventricular tissue | |
| Increase atrial fibrillation susceptibility | ||
| Kir 6.2 | Pancreatic islet cell | Neonatal diabetes mellitus, maturity-onset diabetes of the young 13, type 2 diabetes mellitus, and even persistent hyperinsulinemic hypoglycemia of infancy |
| rs5215 G/G | Vasodilation augment and shear stress reduction | |
| Hypertension mouse model | Heart failure and death, myocardial incommensurate remodeling | |
| p.V59M | Intellectual disability | |
| SUR1 | Pancreas | Neonatal diabetes |
| V187D | Higher insulin secretion in hypoglycemia and make KATP channel acting pharmaceuticals out of action | |
| p.H1401Tfs | Clinical heterogeneity congenital hyperinsulinemia | |
| Unstated | Increased channel activity in MgATP/MgADP, reduced the KATP channel surface expression | |
| SUR2A | Fs1524 and A1513T | Severely dilated hearts with impaired systolic function and arrhythmia |
| SUR2B | R659C | Heart disease and early repolarization syndrome |
| C24S and C1455S | Prevent the detrimental effects of sulfhydration and NaHS-induced tyrosine nitration |